Unresectable, locally advanced PD-L1 positive Lung Cancer Non-Small Cell Cancer (NSCLC)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB11714 | Durvalumab | An antineoplastic monoclonal antibody used to treat urothelial carcinoma and locally advanced, unresectable non-small cell lung cancer. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB11714 | Durvalumab | Programmed cell death 1 ligand 1 | target |
| DB11714 | Durvalumab | Programmed cell death protein 1 | target |
| Drug | Drug Name | Phase | Status | Count |
|---|